HSIC Henry Schein Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: HSIC

Price (delayed)

$86.155

Market cap

$9.52B

P/E Ratio

23.41

Dividend/share

N/A

EPS

$3.68

Enterprise value

$13.23B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 51

Henry Schein, Inc. is a products, services, and technology platforms company for healthcare customers. With more than 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more ...

Highlights
The EPS has increased by 15% YoY and by 7% from the previous quarter
The company's gross profit rose by 8% YoY
The quick ratio is down by 5% year-on-year but it is up by 3.6% since the previous quarter
HSIC's debt is up by 13% YoY and by 2% from the previous quarter
HSIC's P/E is 10% above its 5-year quarterly average of 21.9 and 3.6% above its last 4 quarters average of 23.2
Sector: Healthcare
Industry: Medical Distribution
Website: http://www.henryschein.com
Peers: CAH ACH MCK IDXX

Key stats

What are the main financial stats of HSIC

HSIC stock price

How has the Henry Schein stock price performed over time
Intraday
-2.56%
1 week
0.99%
1 month
2.29%
1 year
18.28%
YTD
13.99%
QTD
2.6%

Financial performance

How have Henry Schein's revenue and profit performed over time
Revenue
$13.73B
Gross profit
$4.34B
Operating income
$709M
Net income
$421M
Gross margin
31.6%
Net margin
3.1%
The company's operating income rose by 10% YoY and by 4.3% QoQ
The company's gross profit rose by 8% YoY
HSIC's net income is up by 8% year-on-year and by 4.5% since the previous quarter
Henry Schein's revenue has increased by 6% YoY

Price vs fundamentals

How does HSIC's price correlate with its fundamentals

Growth

What is Henry Schein's growth rate over time

Valuation

What is Henry Schein stock price valuation
HSIC P/E details
P/E
23.41
P/B
3.04
P/S
0.7
EV/EBIT
18.25
EV/EBITDA
12.51
EV/Sales
0.96
The EPS has increased by 15% YoY and by 7% from the previous quarter
HSIC's P/E is 10% above its 5-year quarterly average of 21.9 and 3.6% above its last 4 quarters average of 23.2
The P/B is 11% more than the 5-year quarterly average of 2.8 and 8% more than the last 4 quarters average of 2.9
The equity is down by 6% year-on-year
The price to sales (P/S) is 10% lower than the 5-year quarterly average of 0.8 but 2.9% higher than the last 4 quarters average of 0.7
Henry Schein's revenue has increased by 6% YoY

Efficiency

How efficient is Henry Schein business performance
Henry Schein's return on equity has increased by 13% YoY and by 6% QoQ
The ROIC has grown by 3.6% from the previous quarter
The ROS has increased by 3.9% from the previous quarter and by 3.9% YoY
HSIC's ROA is up by 2.8% since the previous quarter

Dividends

What is HSIC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HSIC.

Financial health

How did Henry Schein financials performed over time
Henry Schein's total assets is 70% higher than its total liabilities
Henry Schein's total liabilities has increased by 9% YoY
The quick ratio is down by 5% year-on-year but it is up by 3.6% since the previous quarter
HSIC's debt is 23% more than its equity
The debt to equity has grown by 21% YoY
HSIC's debt is up by 13% YoY and by 2% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.